Search

James J Droste

from Indianapolis, IN
Age ~59
Get Report
Also known as:
James J Oroste, James J Drost
Phone and address:
7430 Wood Stream Dr, Indianapolis, IN 46254
(317) 388-8791
Related to:
Gregory C Stawara, 59Alex Stawara, 32Jerome L Stawara, 66Alexis Stawara, 32Justin Z AminorChristopher K Stawara, 60Patricia Stawara, 88
Connected to:
Brad N Droste, 56Frank E Droste, 71John F Droste, 72Alex DrotenkoErich A Drotleff, 59Karl R Drotning, 74Tiffiny Drotos, 42Lina DrottEric C Drottar, 46Ellyn I Drotzer, 57

James Droste Phones & Addresses

  • 7430 Wood Stream Dr, Indianapolis, IN 46254 (317) 388-8791
  • New Richmond, IN
  • Gurnee, IL
  • Montgomery, IN

Work

Position: Professional/Technical

Professional Records

License Records

James Droste

License #:
TCP169655 - Expired
Category:
EMS Licensing
Issued Date:
Sep 16, 2016
Expiration Date:
Dec 15, 2016
Type:
None

Publications

Us Patents

Compounds For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis

View page
US Patent:
6476263, Nov 5, 2002
Filed:
Apr 3, 2001
Appl. No.:
09/826412
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Jon K. Reel - Carmel IN
Warren J. Porter - Indianapolis IN
Jeffrey S. Nissen - Indianapolis IN
Thomas E. Mabry - Indianapolis IN
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Beverly K. Folmer - Newark DE
James J. Droste - Indianapolis IN
Thomas C. Britton - Carmel IN
James E. Audia - Indianapolis IN
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
C07C23300
US Classification:
564152, 564153, 564159, 564160, 564161, 564 41, 560 41, 562450
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis.

Heterocyclic Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6506782, Jan 14, 2003
Filed:
Feb 27, 1998
Appl. No.:
09/032019
Inventors:
Eugene D. Thorsett - Moss Beach CA
Warren J. Porter - Indianapolis IN
Jeffrey S. Nissen - Indianapolis IN
Lee H. Latimer - Oakland CA
James E. Audia - Indianapolis IN
James Droste - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 314245
US Classification:
514364
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6541466, Apr 1, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915362
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421106, 51421107, 51421204, 51421206, 51421207, 51421208, 540488, 540521, 540522, 540523, 540524, 540527
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6544978, Apr 8, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915480
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Bloomington IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421106, 51421107, 51421204, 51421206, 51421207, 51421208, 540488, 540521, 540522, 540523, 540524, 540527
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6559141, May 6, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915564
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421106, 51421107, 51421204, 51421206, 51421207, 51421208, 540488, 540521, 540522, 540523, 540524, 540527
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6579867, Jun 17, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915379
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421106, 51421107, 51421204, 51421206, 51421207, 51421208
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6632811, Oct 14, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915342
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Bloomington IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
514220, 514221
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6635632, Oct 21, 2003
Filed:
Dec 22, 1997
Appl. No.:
08/996422
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421203, 51421204, 51421207, 51421208
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.
Control profile
James J Droste from Indianapolis, IN, age ~59 Get Report